Can Blood Work Detect Melanoma? | What Tests Really Show

A standard blood panel can’t diagnose melanoma, but certain labs can help assess spread, treatment safety, and how your body is handling therapy.

It’d be nice if a single tube of blood could spot melanoma early and settle the question in one shot. In real life, melanoma diagnosis still comes from a skin exam plus a biopsy of the suspicious spot.

Blood work still matters. It just matters for different reasons than most people expect. It can help doctors stage advanced disease, spot patterns that suggest trouble in the liver or other organs, and set a baseline before treatment starts.

Why A Blood Test Can’t Diagnose Melanoma By Itself

Melanoma starts in pigment-making cells in the skin. Early on, the cancer can be tiny and stay local, so there may be nothing measurable in the bloodstream.

Most routine blood tests measure enzymes, blood cell counts, salts, kidney markers, and liver markers. Those numbers can shift for lots of reasons—exercise, infections, medications, dehydration, even a tough week of sleep. That’s why “abnormal labs” don’t point to melanoma on their own.

What Makes A Diagnosis “Real”

A melanoma diagnosis comes from looking at cells under a microscope. That means a biopsy of the skin lesion or, in some cases, a lymph node or another site.

National cancer organizations describe blood tests as tools used around staging and treatment, not as a way to confirm melanoma in the first place. That distinction keeps people from chasing the wrong test and losing time.

Can Blood Work Detect Melanoma In Early Stages?

For early melanoma, blood work usually won’t show a signal that says “this is melanoma.” Many people with stage 0, stage I, or stage II melanoma have normal blood tests.

When melanoma is still confined to the skin, the job is to remove it fully and confirm the depth and other features that affect risk. That work happens with pathology from the biopsy and, when needed, a sentinel lymph node biopsy.

What Blood Work Can Do In Early Disease

Even with early melanoma, a clinician may order labs for practical reasons. Someone may need pre-op blood work, or they may have symptoms that call for broader evaluation.

Those labs don’t diagnose melanoma. They help with readiness for a procedure, safety planning, and sorting out other causes of symptoms.

When Blood Work Starts To Matter More

Blood work becomes more relevant as the melanoma risk picture gets bigger—thicker tumors, lymph node involvement, symptoms that raise concern for spread, or planning systemic therapy.

At that point, the goal shifts. Instead of “Is this melanoma?”, the questions sound like “Has it spread?”, “How is the body doing?”, and “Is treatment safe to start?”

LDH And Why You’ll Hear About It

Lactate dehydrogenase (LDH) is a common lab you’ll see in advanced melanoma workups. LDH is an enzyme found in many tissues. It rises when cells are damaged, so it’s not cancer-specific.

In metastatic melanoma, a higher LDH level can be linked with a harder-to-treat situation and can factor into staging and prognosis. The American Cancer Society notes LDH testing as part of the workup for more advanced cases, tied to spread beyond the skin. Tests for melanoma skin cancer explains how LDH fits into that bigger picture.

Why “High LDH” Doesn’t Automatically Mean Cancer

LDH can rise with many common issues: liver irritation, anemia with cell breakdown, muscle injury, infections, and more. A single LDH value can’t tell you where the problem is coming from.

MedlinePlus makes that plain: an LDH test alone can’t identify the cause or location of the damage, so it’s used alongside other tests. Lactate dehydrogenase (LDH) test gives a clear overview of what the result can and can’t mean.

How Clinicians Use Blood Work Around Melanoma Care

Blood tests in melanoma care usually fall into a few buckets. Some help with staging in later disease. Some help track organ function during treatment. Some help flag side effects early, when they’re easier to handle.

The National Cancer Institute describes melanoma diagnosis as skin-based, while also listing blood tests like LDH among items used in staging and treatment planning for certain cases. Melanoma treatment (PDQ) walks through the testing and staging flow in patient language.

Baseline Labs Before Systemic Treatment

Before immunotherapy or targeted therapy, doctors usually want baseline numbers. Those baselines make it easier to spot treatment-related changes later.

Common baseline labs include a complete blood count (CBC), a comprehensive metabolic panel (CMP) that includes liver and kidney markers, and sometimes thyroid labs. The exact list depends on the treatment plan and the person’s health history.

Safety Monitoring During Treatment

Many modern melanoma treatments can affect organs like the liver, kidneys, or thyroid, even when they’re working well at the start. Blood work helps catch those shifts early.

Monitoring schedules vary. Some people get labs before each infusion or at set intervals, while others get labs based on symptoms and treatment type.

Blood Tests You Might See In Melanoma Workups

Not every test below is ordered for every person. Some are common “baseline” labs. Others show up mainly in advanced disease or during systemic therapy.

The National Comprehensive Cancer Network patient guideline notes that blood tests aren’t used to diagnose melanoma and are more often used before or during treatment, especially in advanced disease. NCCN Guidelines for Patients: Melanoma summarizes how labs like LDH fit into later-stage care.

What Each Test Can And Can’t Tell You

A helpful way to think about labs is this: most of them describe your body’s response, not the tumor’s identity. They can hint at spread, organ strain, inflammation, or treatment side effects.

They can’t replace a biopsy. They also can’t reliably “rule out” melanoma when they’re normal.

Test Or Marker	What A Change Might Suggest	Where It’s Used Most
LDH	Higher levels can align with metastatic burden or tissue damage from other causes	Advanced melanoma staging and prognosis
CBC (red/white cells, platelets)	Anemia, infection patterns, immune shifts, marrow stress, treatment effects	Baseline and ongoing monitoring during therapy
CMP (kidney markers, electrolytes)	Dehydration, kidney strain, electrolyte imbalance, medication effects	Baseline and safety checks during treatment
Liver enzymes (AST/ALT, alkaline phosphatase, bilirubin)	Liver irritation from many causes; can also rise with liver involvement or treatment side effects	Advanced disease workup and treatment monitoring
Thyroid labs (TSH, free T4)	Thyroid inflammation or under/overactivity, seen with some immunotherapies	Monitoring during immune checkpoint therapy
Glucose and A1C (when ordered)	Blood sugar shifts; steroids used for side effects can raise glucose	Safety planning, side-effect management
Inflammation markers (CRP, ESR, when ordered)	General inflammation; not tumor-specific	Symptom workups, treatment side-effect puzzles
Viral screening (hepatitis B/C, HIV, when ordered)	Infection status that may affect treatment choices or monitoring	Baseline planning for systemic therapy in selected cases
Circulating tumor DNA tests (ctDNA, when available)	Fragments of tumor DNA in blood; may help track disease in some settings	Selected advanced cases, research settings, recurrence monitoring in some centers

So What Tests Actually Detect Melanoma?

If you’re trying to detect melanoma, the front-line tools aren’t blood tests. The starting point is a skin check plus a biopsy of any suspicious spot.

After diagnosis, the medical team may add imaging or lymph node evaluation based on the tumor’s features, the physical exam, and symptoms.

Skin Exam And Dermoscopy

Clinicians look for asymmetry, border irregularity, color variation, diameter changes, and evolution over time. Dermoscopy gives a closer look at pigment networks and vascular patterns that the naked eye can’t see well.

These exams help decide which spots need biopsy. They do not confirm melanoma without pathology.

Biopsy And Pathology

A biopsy samples the lesion so a pathologist can measure thickness, ulceration, and other features tied to risk. That report guides the next steps.

If the biopsy shows melanoma, the care plan depends on depth and whether there are signs of spread.

Sentinel Lymph Node Biopsy And Imaging

For some melanomas, a sentinel lymph node biopsy checks the first lymph node(s) that drain the tumor area. If melanoma cells are found there, staging changes and treatment options broaden.

Imaging like CT, PET/CT, or MRI may be used when staging indicates higher risk or when symptoms raise concern for spread.

What To Do If You’re Waiting On Blood Work

Waiting is rough. A lot of people latch onto lab results because they feel concrete. The catch is that labs rarely give a clean yes-or-no answer for melanoma.

If you have a concerning skin spot, the fastest path to clarity is getting that spot evaluated and biopsied when indicated. Blood tests can come later if the clinical picture calls for them.

Red Flags That Deserve Prompt Skin Evaluation

Look for a spot that changes in size, shape, or color, or one that bleeds without a clear reason. A new dark streak under a nail or a sore that doesn’t heal can also be a sign worth checking.

Symptoms like unexplained weight loss, persistent headaches, shortness of breath, or new bone pain deserve medical attention too, since they can signal many conditions, including advanced cancer.

Goal	Best First Tool	What To Ask At The Visit
Find out if a skin spot is melanoma	Skin exam + biopsy if indicated	“Does this lesion need biopsy today?”
Stage confirmed melanoma	Pathology report + targeted staging tests	“What stage features are present on pathology?”
Check for spread in higher-risk cases	Imaging and lymph node evaluation when appropriate	“Do my features call for lymph node testing or imaging?”
Set a baseline before systemic therapy	CBC/CMP and other labs tied to the drug plan	“Which labs will you track during treatment?”
Track treatment safety	Scheduled labs + symptom check-ins	“What symptoms should trigger a same-day call?”
Follow advanced disease over time	Imaging, symptom trends, selected labs like LDH	“Which results will change the plan if they shift?”

How To Read Common Results Without Spiraling

A single abnormal value can be noise. Patterns matter more than one-off blips. Trends over time matter more than a single draw taken on a stressful day.

If something is out of range, the next step is usually context: symptoms, meds, recent illness, hydration, and other labs drawn at the same time.

LDH: A Useful Marker With A Wide Net

LDH can help in advanced melanoma because it correlates with outcomes in metastatic disease. It still can’t pinpoint melanoma on its own.

If LDH is elevated, clinicians often check whether there’s a clear non-cancer reason first, then interpret it alongside imaging and the rest of the clinical story.

Liver And Kidney Numbers: Often About Treatment Safety

Melanoma treatments can stress the liver or kidneys in some people. Blood work can catch that early, before symptoms become intense.

If you’re on therapy, ask which lab shifts matter for your specific drugs, since thresholds vary by regimen.

What’s Next If Melanoma Is Confirmed

Once melanoma is confirmed, the plan usually follows a clear sequence: confirm removal of the primary lesion, decide whether lymph nodes need evaluation, then consider systemic therapy based on stage and risk features.

Blood work fits into that sequence as a supporting tool. It helps with baselines, safety, and—mainly in later stages—adds a bit more information about disease burden.

Questions That Keep The Visit Productive

Ask for the pathology report in plain language: thickness, ulceration, margins, and whether further excision is needed. Ask what follow-up schedule is recommended and what changes on your skin should prompt an earlier check.

If treatment is on the table, ask which labs you’ll be repeating and what symptoms should trigger urgent contact.